Johnson Chemical Pharmaceutical Works Co., Ltd.(TW:4747)
NT$15.80-1.75 (-9.97%)
TW:4747
Johnson Chemical Pharmaceutical Works Co., Ltd. financials statements
NT$15.80
At close:-1.75 (-9.97%)
Johnson Chemical Pharmaceutical Works Co., Ltd. (4747) Ratios
Johnson Chemical Pharmaceutical Works Co., Ltd. Ratios
TW:4747's free cash flow for Q2 2026 was NT$2.20M. For the 2026 fiscal year, TW:4747's free cash flow was decreased by NT$-12.21M and operating cash flow was NT$14.40M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.79 | 7.81 | 6.18 | 2.47 | 2.50 |
| Quick Ratio | 3.30 | 6.99 | 5.54 | 1.72 | 1.68 |
| Cash Ratio | 2.73 | 6.25 | 4.94 | 1.01 | 1.13 |
| Solvency Ratio | 0.19 | 0.40 | 0.31 | 0.50 | 0.36 |
| Operating Cash Flow Ratio | 0.19 | 0.37 | 0.62 | 0.54 | 0.29 |
| Short-Term Operating Cash Flow Coverage | 0.27 | 1.05 | 2.28 | 1.49 | 0.65 |
| Net Current Asset Value | NT$ 1.07B | NT$ 1.08B | NT$ 1.04B | NT$ 246.96M | NT$ 267.58M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.12 | 0.08 | 0.08 | 0.06 | 0.08 |
| Debt-to-Equity Ratio | 0.15 | 0.09 | 0.10 | 0.07 | 0.09 |
| Debt-to-Capital Ratio | 0.13 | 0.08 | 0.09 | 0.06 | 0.09 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.05 | 0.06 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.22 | 1.15 | 1.19 | 1.19 | 1.21 |
| Debt Service Coverage Ratio | 0.32 | 1.71 | 1.63 | 1.39 | 0.81 |
| Interest Coverage Ratio | 19.58 | 27.95 | 21.51 | 78.97 | 58.51 |
| Debt to Market Cap | 0.10 | 0.05 | 0.05 | 0.04 | 0.08 |
| Interest Debt Per Share | 2.94 | 1.70 | 2.32 | 0.92 | 1.22 |
| Net Debt to EBITDA | -8.42 | -6.91 | -7.32 | -1.07 | -1.56 |
| Profitability Margins | |||||
| Gross Profit Margin | 40.08% | 40.56% | 40.32% | 41.32% | 41.78% |
| EBIT Margin | 12.87% | 18.35% | 17.39% | 16.54% | 15.14% |
| EBITDA Margin | 16.44% | 21.78% | 20.87% | 20.57% | 19.03% |
| Operating Profit Margin | 12.87% | 16.03% | 16.29% | 16.87% | 15.31% |
| Pretax Profit Margin | 11.12% | 17.78% | 16.63% | 16.48% | 15.05% |
| Net Profit Margin | 9.39% | 13.76% | 13.14% | 13.11% | 11.93% |
| Continuous Operations Profit Margin | 9.39% | 13.76% | 13.14% | 13.11% | 11.93% |
| Net Income Per EBT | 84.42% | 77.38% | 79.00% | 79.54% | 79.27% |
| EBT Per EBIT | 86.42% | 110.93% | 102.08% | 97.68% | 98.29% |
| Return on Assets (ROA) | 2.56% | 4.28% | 4.00% | 6.24% | 4.78% |
| Return on Equity (ROE) | 3.13% | 4.94% | 4.77% | 7.44% | 5.79% |
| Return on Capital Employed (ROCE) | 4.29% | 5.46% | 5.57% | 9.58% | 7.43% |
| Return on Invested Capital (ROIC) | 3.14% | 4.09% | 4.26% | 7.13% | 5.38% |
| Return on Tangible Assets | 2.56% | 4.28% | 4.00% | 6.27% | 4.81% |
| Earnings Yield | 2.01% | 2.61% | 2.68% | 4.22% | 4.67% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.93 | 5.08 | 4.80 | 4.25 | 4.44 |
| Payables Turnover | 5.83 | 9.10 | 5.34 | 8.71 | 6.85 |
| Inventory Turnover | 1.81 | 2.58 | 2.61 | 2.29 | 1.64 |
| Fixed Asset Turnover | 0.94 | 1.02 | 1.00 | 0.84 | 1.08 |
| Asset Turnover | 0.27 | 0.31 | 0.30 | 0.48 | 0.40 |
| Working Capital Turnover Ratio | 0.51 | 0.53 | 0.88 | 1.92 | 1.44 |
| Cash Conversion Cycle | 212.87 | 173.20 | 147.61 | 203.63 | 252.00 |
| Days of Sales Outstanding | 74.04 | 71.82 | 76.05 | 85.80 | 82.14 |
| Days of Inventory Outstanding | 201.48 | 141.50 | 139.93 | 159.72 | 223.17 |
| Days of Payables Outstanding | 62.65 | 40.13 | 68.37 | 41.89 | 53.31 |
| Operating Cycle | 275.52 | 213.32 | 215.98 | 245.52 | 305.31 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.80 | 0.70 | 1.92 | 1.35 | 0.79 |
| Free Cash Flow Per Share | 0.09 | 0.55 | 1.46 | 0.45 | 0.23 |
| Dividend Paid and CapEx Coverage Ratio | 0.50 | 0.78 | 1.47 | 0.87 | 0.55 |
| Capital Expenditure Coverage Ratio | 1.12 | 4.77 | 4.14 | 1.50 | 1.40 |
| Operating Cash Flow Coverage Ratio | 0.27 | 0.42 | 0.85 | 1.49 | 0.65 |
| Operating Cash Flow to Sales Ratio | 0.13 | 0.10 | 0.23 | 0.18 | 0.13 |
| Free Cash Flow Yield | 0.29% | 1.54% | 3.49% | 1.95% | 1.43% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 49.75 | 38.24 | 37.37 | 21.49 | 21.33 |
| Price-to-Sales (P/S) Ratio | 4.67 | 5.27 | 4.91 | 3.11 | 2.56 |
| Price-to-Book (P/B) Ratio | 1.56 | 1.89 | 1.78 | 1.76 | 1.24 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 347.49 | 64.89 | 28.68 | 51.28 | 69.89 |
| Price-to-Operating Cash Flow Ratio | 37.12 | 51.28 | 21.75 | 17.14 | 20.10 |
| Price-to-Earnings Growth (PEG) Ratio | -1.37 | -2.31 | 10.09 | 0.48 | -0.95 |
| Enterprise Value Multiple | 20.00 | 17.30 | 16.20 | 14.04 | 11.88 |
| Enterprise Value | 1.87B | 2.30B | 2.05B | 1.43B | 930.20M |
| EV to EBITDA | 20.00 | 17.30 | 16.20 | 14.04 | 11.88 |
| EV to Sales | 3.29 | 3.77 | 3.38 | 2.89 | 2.26 |
| EV to Free Cash Flow | 244.54 | 46.38 | 19.76 | 47.66 | 61.77 |
| EV to Operating Cash Flow | 26.12 | 36.65 | 14.98 | 15.93 | 17.77 |
| Tangible Book Value Per Share | 19.01 | 18.88 | 23.46 | 13.10 | 12.72 |
| Shareholders’ Equity Per Share | 19.01 | 18.89 | 23.50 | 13.16 | 12.81 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.16 | 0.23 | 0.21 | 0.20 | 0.21 |
| Revenue Per Share | 6.34 | 6.78 | 8.53 | 7.47 | 6.21 |
| Net Income Per Share | 0.60 | 0.93 | 1.12 | 0.98 | 0.74 |
| Tax Burden | 0.84 | 0.77 | 0.79 | 0.80 | 0.79 |
| Interest Burden | 0.86 | 0.97 | 0.96 | 1.00 | 0.99 |
| Research & Development to Revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 |
| SG&A to Revenue | 0.24 | 0.21 | 0.21 | 0.22 | 0.24 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Income Quality | 1.13 | 0.58 | 1.36 | 1.10 | 0.85 |
Currency in TWD
